BridgeBio Pharma, Inc. Treasury Stock, Common, Value
BridgeBio Pharma, Inc. (BBIO) had Treasury Stock, Common, Value of $533.28 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent › Treasury Stock, Value
us-gaap:TreasuryStockCommonValue · last filed 2026-08-10
- 2026-06-30: Treasury Stock, Common, Value $533.28M.
- 2026-03-31: Treasury Stock, Common, Value $405.78M.
- 2025-12-31: Treasury Stock, Common, Value $323.28M.
- 2025-09-30: Treasury Stock, Common, Value $323.28M.
| Period end | Treasury Stock, Common, Value |
|---|---|
| 2026-06-30 | $533.28M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $405.78M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $323.28M 10-Q · filed 2026-08-10 |
| 2025-09-30 | $323.28M 10-Q · filed 2025-10-29 |
| 2024-12-31 | $275.00M 10-K · filed 2026-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |